Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3 | 0 | N/A | 0 | 0 |
| Receivables | 94 | 0 | N/A | 0 | 0 |
| Other current assets | 204 | 0 | 0 | 0 | 0 |
| TOTAL | $348 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 290 | N/A | N/A | N/A | N/A |
| Investments And Advances | 782 | 0 | 0 | 0 | 0 |
| Intangibles | 44,570 | 0 | 0 | 0 | 0 |
| TOTAL | $45,642 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $45,990 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 301 | 0 | 0 | 0 | 0 |
| TOTAL | $12,055 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 19 | 192 | 0 | 67 | 67 |
| TOTAL | $3,235 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $15,290 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,877,282 | N/A | N/A | N/A | N/A |
| Common Shares | 125 | 0 | N/A | 0 | 0 |
| Retained earnings | -10,564 | 0 | N/A | 0 | 0 |
| Other shareholders' equity | 3,081 | 0 | 0 | 0 | 0 |
| TOTAL | $30,700 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $45,990 | $0 | $0 | $0 | $0 |